Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Interest & Investment Income: 2022-2024

Historic Interest & Investment Income for Maravai Lifesciences Holdings (MRVI) over the last 3 years, with Dec 2024 value amounting to $27.4 million.

  • Maravai Lifesciences Holdings' Interest & Investment Income fell 60.44% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.1 million, marking a year-over-year decrease of 47.66%. This contributed to the annual value of $27.4 million for FY2024, which is 1.17% down from last year.
  • Per Maravai Lifesciences Holdings' latest filing, its Interest & Investment Income stood at $27.4 million for FY2024, which was down 1.17% from $27.7 million recorded in FY2023.
  • In the past 5 years, Maravai Lifesciences Holdings' Interest & Investment Income ranged from a high of $27.7 million in FY2023 and a low of $2.3 million during FY2022.
  • Over the past 3 years, Maravai Lifesciences Holdings' median Interest & Investment Income value was $27.4 million (recorded in 2024), while the average stood at $19.2 million.
  • Its Interest & Investment Income has fluctuated over the past 5 years, first spiked by 1,085.93% in 2023, then decreased by 1.17% in 2024.
  • Yearly analysis of 3 years shows Maravai Lifesciences Holdings' Interest & Investment Income stood at $2.3 million in 2022, then skyrocketed by 1,085.93% to $27.7 million in 2023, then declined by 1.17% to $27.4 million in 2024.